GO
Loading...

Blackstone Unit to Acquire DJO for $1.3 Billion

A unit of private equity giant Blackstone Groupwill buy knee and ankle brace maker DJOfor $1.3 billion, the companies said on Monday.

The cash offer of $50.25 per share represents a 19 percent premium over DJO's closing price of $42.10 on Friday.

The deal will bring together DJO and medical device maker ReAble Therapeutics, formerly known as Encore Medical. The companies make complementary orthopedic and pain-management products, DJO said.

A Blackstone affiliate is the controlling shareholder of ReAble. The affiliate will provide the equity financing for the deal.

Biomet, a much larger orthopedic products maker, last month agreed to a sweetened takeover bid of $11.4 billion from a group of private equity firms that includes Blackstone.

The DJO transaction is worth $1.6 billion, including $300 million of assumed debt, and is expected to close in the fourth quarter.

DJO will have to pay ReAble a break-up fee of $18.7 million if the deal falls through. The DJO board has unanimously approved the transaction.

Wachovia Securities is the financial advisor to DJO, while Credit Suisse is advising ReAble and Blackstone.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • CNBC's Morgan Brennan reports on some of the creative ways drillers are cutting down on the controversial practice of burning off excess gas produced in the Bakken.

  • Bruce Ratner, Barclays Center majority owner, shares his hopes of holding the 2016 Democratic convention in Brooklyn, New York. You have an economic impact that far exceeds any inconvenience that may happen, says Ratner, discussing the benefits of hosting the event.

  • CNBC's Steve Liesman talks to Kansas City Fed President Esther George about market complacency and the future of interest rates.